Pediatric & Geriatric Pharmacology Flashcards
Pediatric loading dose - considerations
Body proportions of fat and distribution have little effect on Vd; loading doses change little for children
Cp (mg/L) = Dose (mg) / Vd (L)
Grey Baby Syndrome
Chloramphenicol toxicity in infants
Due to inadequacy of hepatic glucuronidation (Phase II conjugation)
Hepatic vs. renal clearance in kids
Hepatically eliminated drugs have clearances that vary widely in children due to multiple enzyme systems that mature at independent rates; requires careful monitoring
Renal clearance of drugs is generally more predictable and occurs more rapidly in children than in adults
Drugs that affect growth in children
Psychoactive agents - i.e. methylphenidate (due to appetite suppression / sleep disturbance)
Corticosteroids (including topical / inhalted) - via inhibition of pituitary GH release
Use of salicylates in children
Increased risk of Reyes syndrome - fatty liver + acute encephalopathy; especially in use following viral infection
Use of tetracyclines in children
Tetracyclines are incorporated into growing bone and deeth; contraindicated in children < 8 years old and during pregnancy
Absorption consideration in geriatrics
Decreased gastric acid absorption; decreased absorption of weak acid drugs (warfarin, penicillin) vs. increased absorption of weak base drugs (TCADs, benzos, opioids)
Decreased gastric emptying / GI motility; exacerbated by anticholinergic drugs (TCADs, diphenhydramine)
Decreased splanchnic blood flow
Distribution considerations in geriatrics
Decreased water / lean body mass and increased adipose
Vd is decreased for water-soluble drugs causing higher plasma concentrations with increased risk of toxicity
Vd is increased for lipid-soluble drugs causing drug accumulation and prolonged elimination
Water-soluble drugs - require lower loading dose in geriatrics
Digoxin
Aminoglycosides
Lithium
May require lower loading dose
Lipid soluble drugs - require lower maintenance dose in geriatrics
Chloriazepoxide
Diazepam
Changes in hepatic metabolism with age
Hepatic mass / hepatic blood flow decreases 1%/year after age 40
Phase I hepatic metabolism decreases by ~30% with age; Phase II hepatic metabolism is less affected
Thus, drugs that are metabolized by phase II hepatic metabolism (oxazepam, lorazepam) are more reliably eliminated in geriatric patients than are phase I metabolized drugs (diazepam)
Renal Dosing - Considerations
GFR decreases by ~ 10mL / decade along with decreased elimination of renally cleared drugs
Adjust dose based on CrCl but remember that serum Cr may be “normal” even in the setting of decreased renal function due to decreased muscle mass in elderly
Drugs that exacerbate arthralgias, myopathies, osteoporosis
Corticosteroids
Phenytoin
Heparin / warfarin
Drugs that exacerbate movement disorders
Dopamine receptor blockers - antipsychotic agents, metoclopramide
Drugs that exacerbate tinnitus / vertigo
Aspirin
Aminoglycosides
Ethacrynic acid